Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: Association with time of onset and diabetic state

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 3, 2006, Pages 639-646

  Licata, G ^a   Tuttolomondo, Antonino ^a   Corrao, S ^a   Di Raimondo, D ^a   Fernandez, P ^a   Caruso, C ^b   Avellone, G ^a   Pinto, A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cytokines; Selectins; Stroke

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA ANTIBODY; INTERLEUKIN 6; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BRAIN INFARCTION SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPTOMATOLOGY;

EID: 33750071449     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900320     Document Type: Article

References (20)

1. Jamrozik K., R.J. Boradhurst, C.S. Anderson and E.G. Stewart-Wynne. 1994. The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia. Stroke 25:51.
2. Megherbi S.E., C. Milan, D. Minier, G. Couvreur, G.V. Osseby, K. Tilling, A. Di Carlo, D. Inzitari, C.D. Wolfe, T. Moreau and M. Giroud for the European BIOMED Study of Stroke Care Group. 2003. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke. Data from the European BIOMED Stroke Project. Stroke 34:688.
3. Karapanaiotides T.H., B. Piechowski-Jozwiak, G. Van Melle, J. Bogousslavsky and G. Devuyst. 2004. Stroke patterns, etiology and prognosis in patients with diabetes mellitus. Neurology 62:1558.
4. Del Zoppo G., I. Ginis, J.M. Hallenback, C. Iadecola, X. Wang and G.Z. Feuerstein. 2000. Inflammation and stroke: putative role for cytokines, adhesion molecules and i-NOS in brain response to ischemia. Brain Pathol. 10:95.
5. Conolly E.S. Jr, C.J. Winfree, T.A. Springer, Y. Naka, H. Liao, S.D. Yan, D.M. Stern, R.A. Solomon, J.C. Gutierrez-Ramoz and D.J. Pinsky. 1996. Cerebral protection in homozygous null ICAM-1 after middle cerebral artery occlusion: role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 7:209.
6. Adams H.P., B.H. Bendixen, J. Kappelle, J. Biller, B. Love, M.D. Gordon, E.E. Marsh and the TOAST Investigators. 1993. Classification of subtype of acute ischemic stroke. Stroke 24:35.
7. Licata G., A. Tuttolomondo and A. Pinto. 2004. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 35:61.
8. Pinto A., A. Tuttolomondo, D. Di Raimondo, P. Fernandez and G. Licata. 2004. Cerebrovascular risk factors and clinical classification of strokes. Semin. Vasc. Med. 4:287.
9. Tuttolomondo A., A. Pinto, D. Di Raimondo, P. Fernandez and G. Licata. 2005. Stroke patterns, etiology and prognosis in patients with diabetes mellitus. Neurology 64:581.
10. Buttini M., A. Sauter and H.W. Boddeke. 1994. Induction of interleukin-1 beta mRNA after focal cerebral ischaemia in the rat. Mol. Brain Res. 23:126.
11. Eriksson C., A.M. Van Dam, P.J. Lucassen, J.G. Bol, B. Winblad and M. Schultzberg. 1999. Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1 beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience 93:915.
12. Shalaby M.R., B.B. Aggarwal and E. Rinderknechte. 1985. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factor. J. Immunol. 135:2069.
13. Pober J.S. and R.S. Cotran. 1990. Cytokines and endothelial cell biology. Physiol. Rev. 70:427.
14. Dong J., S. Fujii, D. Goto, T. Furumoto, T. Kaneko, T. Zaman, Y. Nakai, T. Mishima, S. Magawa and A. Kitabatake. 2003. Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in Hypertensives. Hypertens. Res. 26:723.
15. Calles-Escandon J., S.A. Mirza, B.E. Sobel and D.J. Schneider. 1998. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes 47:290.
16. Hillen T., C. Coshall, K. Tilling, A. Rudd, R. McGovern and C. Wolfe. 2003. Cause of stroke recurrence is multifactorial. Patterns, risk factors and outcome of stroke recurrence in the South London, Stroke Register. Stroke 34:1457.
17. Gill J.B., D.J. Scneider, C.L. Artken, C.L. Lucore and B.E. Sobel. 1994. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43:104.
18. Peress N.S. and W.C. Kane. 1973. Central nervous system findings in tenth decade autopsypopulation. Prog. Brain Res. 40:473.
19. Okada Y., B.R. Copeland, E. Mori, M.M. Tung, W.S. Thomas and G.J. Del Zoppo. 1994. P-Selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25:202.
20. Flex A., E. Gaetani, P. Papaleo, G. Straface, A.S. Proia, G. Pecorini, P. Tondi, P. Pola and R. Pola. 2004. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35:2270.